COVID-19 and vaccination: myths vs science

被引:22
作者
Chavda, Vivek P. [1 ]
Chen, Yangmin [2 ]
Dave, Jayant [3 ]
Chen, Zhe-Sheng [4 ]
Chauhan, Subhash C. [5 ,6 ]
Yallapu, Murali M. [5 ,6 ]
Uversky, Vladimir N. [7 ,8 ]
Bezbaruah, Rajashri [9 ]
Patel, Sandip [10 ]
Apostolopoulos, Vasso [11 ,12 ]
机构
[1] LM Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Ahmadabad 380009, Gujarat, India
[2] St Johns Univ, Peter J Tobin Coll Business, Queens, NY USA
[3] LM Coll Pharm, Dept Pharmaceut Qual Assurance, Ahmadabad, Gujarat, India
[4] St Johns Univ, Coll Pharm & Hlth Sci, Queens, NY USA
[5] Univ Texas Rio Grande Valley, Sch Med, Dept Immunol & Microbiol, Mcallen, TX USA
[6] Univ Texas Rio Grande Valley, Sch Med, South Texas Ctr Excellence Canc Res, Mcallen, TX USA
[7] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA
[8] Univ S Florida, Byrd Alzheimers Res Inst, Morsani Coll Med, Tampa, FL 33620 USA
[9] Dibrugarh Univ, Dept Pharmaceut Sci, Fac Sci & Engn, Dibrugarh, Assam, India
[10] LM Coll Pharm, Dept Pharmacol, Ahmadabad, Gujarat, India
[11] Victoria Univ, Inst Hlth & Sport, Immunol & Translat Res Grp, Melbourne, Vic, Australia
[12] Australian Inst Musculoskeletal Sci AIMSS, Immunol Program, Melbourne, Vic, Australia
关键词
COVID-19; SARS-CoV-2; myths about COVID-19; vaccines for COVID-19; human lessons; vaccination; LIVE ATTENUATED VACCINES; MESSENGER-RNA VACCINES; CORONAVIRUS; PERSPECTIVES; SAFETY;
D O I
10.1080/14760584.2022.2114900
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 (COVID-19) in December 2019, at unprecedented speed. However, these rapidly developed vaccines raised many questions related to the efficacy and safety of vaccines in different communities across the globe. Various hypotheses regarding COVID-19 and its vaccines were generated, and many of them have also been answered with scientific evidence. Still, there are many myths/misinformation related to COVID-19 and its vaccines, which create hesitancy for COVID-19 vaccination, and must be addressed critically to achieve success in the battle against the pandemic. Area Covered The development of anti-SARS-CoV-2 vaccines against COVID-19, their safety and efficacy, and myths/misinformation relating to COVID-19 and vaccines are presented. Expert Opinion In this pandemic, we have seen a global collaborative effort of researchers, governments, and industry, supported by billions of dollars in funding, have allowed the development of vaccines far more quickly than in the past. Vaccines go through rigorous testing, analysis, and evaluations in clinical settings prior to their approval, even if they are approved for emergency use. Despite the myths, vaccination represents an important strategy to get back to normality.
引用
收藏
页码:1603 / 1620
页数:18
相关论文
共 182 条
[1]   New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications [J].
Abdool Karim, Salim S. ;
de Oliveira, Tulio .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19) :1866-1868
[2]   Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data [J].
Ali, Nurshad .
FRONTIERS IN MEDICINE, 2020, 7
[3]   SARS-CoV-2 Vaccines: Status Report [J].
Amanat, Fatima ;
Krammer, Florian .
IMMUNITY, 2020, 52 (04) :583-589
[4]   Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines [J].
Andrews, Nick ;
Tessier, Elise ;
Stowe, Julia ;
Gower, Charlotte ;
Kirsebom, Freja ;
Simmons, Ruth ;
Gallagher, Eileen ;
Thelwall, Simon ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin ;
Hopkins, Susan ;
Chand, Meera ;
Ladhani, Shamez N. ;
Ramsay, Mary ;
Bernal, Jamie Lopez .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04) :340-350
[5]  
[Anonymous], 2005, QUALITY RISK MANAGEM
[6]  
[Anonymous], VACCINE HESITANCY UN
[7]   Clinical trials for coronavirus disease 2019: What is being evaluated and what is not [J].
Arabi, Yaseen M. ;
Asseri, Ayed ;
Webb, Steve ;
Marshall, John ;
Al Moamary, Mohamed S. .
ANNALS OF THORACIC MEDICINE, 2020, 15 (02) :49-51
[8]   Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines [J].
Araf, Yusha ;
Akter, Fariya ;
Tang, Yan-dong ;
Fatemi, Rabeya ;
Parvez, Md Sorwer Alam ;
Zheng, Chunfu ;
Hossain, Md Golzar .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) :1825-1832
[9]  
Arruda E., 2009, TROP INFECT DIS INTE, P637
[10]   Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control [J].
Azuma, Kenichi ;
Yanagi, U. ;
Kagi, Naoki ;
Kim, Hoon ;
Ogata, Masayuki ;
Hayashi, Motoya .
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE, 2020, 25 (01)